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Abstract
Protein tyrosine phosphatase r (PTPr) belongs to the classical receptor type IIB family of protein tyrosine phosphatase, the
most frequently mutated tyrosine phosphatase in human cancer. There are evidences to suggest that PTPr may act as a
tumor suppressor gene and dysregulation of Tyr phosphorylation can be observed in diverse diseases, such as diabetes,
immune deficiencies and cancer. PTPr variants in the catalytic domain have been identified in cancer tissues. These natural
variants are nonsynonymous single nucleotide polymorphisms, variations of a single nucleotide occurring in the coding
region and leading to amino acid substitutions. In this study we investigated the effect of amino acid substitution on the
structural stability and on the activity of the membrane-proximal catalytic domain of PTPr. We expressed and purified as
soluble recombinant proteins some of the mutants of the membrane-proximal catalytic domain of PTPr identified in
colorectal cancer and in the single nucleotide polymorphisms database. The mutants show a decreased thermal and
thermodynamic stability and decreased activation energy relative to phosphatase activity, when compared to wild- type. All
the variants show three-state equilibrium unfolding transitions similar to that of the wild- type, with the accumulation of a
folding intermediate populated at ,4.0 M urea.
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Introduction
The classical protein tyrosine phosphatase (PTP) superfamily
includes 38 proteins which specifically dephosphorylate phospho-
tyrosine residues and, in concert with protein tyrosine kinases,
control a large number of diverse biological processes, such as cell
proliferation, adhesion, apoptosis and migration [1–6]. Reversible
tyrosine phosphorylation controls numerous signaling pathways
which require a right balance between kinase and phosphatase
activity. The involvement of PTP in controlling cellular signaling
has been largely recognized [2,5,7], though the role of PTP in
human diseases has not been explored so extensively as that of
protein kinases. However in diverse diseases, such as cancer,
diabetes and immune deficiencies, dysregulation of Tyr phosphor-
ylation has been observed [4,7,8].
On the basis of their counteracting activity on the oncogenic
protein tyrosine kinase, PTPs have been initially considered as
potential tumor suppressors, however it is clear that several
phosphatases have oncogenic properties [2–6,9]. Over the last
decade a limited number of phophatases have been studied
systematically to evaluate their role in tumorigenesis. In particular,
six mutated phosphatases have been directly linked to colorectal
cancers [1,10]; among the six mutated genes, the PTPRT gene
encoding PTPr (PDB accession code 2OOQ) was found to be
most frequently mutated and it was also mutated in about 20% of
lung and gastric cancer [10].
PTPr belongs to the classical receptor type IIB family of PTP.
The 107 PTPs encoded by the human genome are classified into
four classes, on the basis of the amino acid sequence of their
catalytic domain. Class I includes 61 dual-specificity phosphatases
and 38 classical phosphotyrosine-specific phosphatase which are
further divided into receptor and non-transmembrane groups
[5,7]. The full-length PTPr contains an extracellular domain,
formed by a meprin-A5 antigen-PTP (MAM) domain and Ig-like
and fibronectin type III-like repeats, a single transmembrane
segment and one or two cytoplasmic catalytic domains. The
catalytically active proximal D1 domain is adjacent to the
membrane and is connected to the inactive membrane-distal D2
domain [3,5]. The PTP membrane-proximal catalytic domain
consists of about 280 residues that fold into a highly conserved a/b
structure [4,11]. Conserved functional elements of the catalytic
PTP domain are the PTP signature motif, the mobile ‘‘WPD’’
loop, a highly conserved aspartate residue required for catalysis
and the phosphotyrosine recognition loop.
In cancer tissues several PTPr variants in the catalytic domain
have been identified and there is evidence to suggest that PTPr
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32555may act as a tumor suppressor gene [10]. These natural variants
are nonsynonymous single nucleotide polymorphisms (nsSNPs),
single nucleotide variations occurring in the coding region and
leading to a polypeptide sequence with amino acid substitutions.
A large number of amino acid substitutions originate from
nsSNPs and an increasingly large number of diseases and defects
reported in Human Gene Mutation Database [12] and Online
Mendelian Inheritance in Man (OMIM) [13] are referred to
nsSNPs [14]. Although most nsSNPs are considered not to affect
protein function, computational analysis predicts that around 30%
of protein variants resulting from nsSNPs are less stable than the
most common variant [15]. The effect of disease-causing nsSNPs
on protein structure and function has been widely investigated by
computational analysis, and change in protein stability has been
suggested as the most common mechanism involved in monogenic
disease [16–18]. However, nsSNPs may also affect and modulate
the protein function by altering protein dynamics without affecting
protein stability [19]. Notably, since genetic variations related to
nsSNPs may influence individual susceptibility to complex diseases
such as cancer [20] or response to drugs, a more extended study
about the effect of nsSNPs on protein structure may help in
understanding their role in inducing protein functional changes
[21]. To date there are few experimental data available
concerning the consequences of nsSNPs on protein function and
stability.
In this study we investigate the effect of amino acid substitutions
identified in colorectal cancer [10] and in the single nucleotide
polymorphisms database [18,22,23] on the thermodynamic
stability and on the activity of the membrane-proximal catalytic
domain of PTPr [1,24]. The analysis revealed that, in comparison
to the wild-type, the thermal and thermodynamic stability of all
the mutants are decreased as well as the activation energy relative
to the phosphatase activity, indicating an increase in protein
flexibility of all the PTPr mutants. All the variants show three-
state equilibrium unfolding transitions similar to that of the wild-
type, with the accumulation of a folding intermediate at ,4.0 M
urea.
To our knowledge, this study represents the first spectroscopic
and thermodynamic characterization of human PTPr catalytic
domain and some of its mutants found in cancer. In addition, the
effects of none of the mutations reported in this manuscript on
protein thermodynamic stability has been previously investigated.
Results
Four mutations of the PTPr membrane-proximal catalytic
domain in public databases have been identified: D927G, Q987K,
N1128I and A1118P. Introduction of these mutations resulted in
soluble recombinant protein only for D927G, Q987K and N1128I
whereas the A1118P mutant could not be expressed in the soluble
fraction even when different growth and induction conditions were
used. Mapping of the mutations onto the structure of the PTPr
catalytic domain revealed that A1118P is located in the middle of a
central helix (Fig. 1). It is likely that the introduction of a proline
residue at this position in substitution of alanine will break the
helical secondary structure resulting in misfolding of the catalytic
Figure 1. Location of PTPr mutations. (A) Structure of PTPr (PDB code 2OOQ) shown as a ribbon diagram. Mutated residues are highlighted in
ball and stick and transparent cpk representation and are labelled in red. The active site cystein residue (C1106) is also shown and the catalytically
important WPD loop is coloured in yellow. (B) Local environment of N1128. (C) Local environment of D927.
doi:10.1371/journal.pone.0032555.g001
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(Fig. 1B). This residue is located in a very polar environment with
flanking acidic (E1124, E1127, E1129) and a histidine residue
(H974) located in a neighbouring loop region. D927G and Q987K
are located in solvent exposed loops with little interaction with
other amino acid side chains (Fig. 1C). The solvent accessibility of
the mutated residues Asp-927 and Gln-987 is more than 70% and
Asn-1128 is 49% solvent exposed. The mutation D927G involves
a residue (Asp-927) placed in a 4 residues turn between two coils.
In the wild-type Asp-927 connects different protein secondary
structure regions through hydrogen bonds with three residues.
One hydrogen bond is between the N of the peptide bond and the
OD2 of Asp-947 and the other two hydrogen bonds are between
the carbonyl of the peptide bond and the amidic nitrogens of Lys-
930 and Glu-931. The carboxylic moiety of Asp-927 is completely
solvent exposed and does not apparently make any contact with
other residues.
Spectroscopic characterization of PTPr wild-type and its
mutants
The near-UV CD spectrum of wild-type PTPr shows the
contribution of all aromatic residues and is characterized by two
negative components centred at 280 nm and at around 298 nm
accompanied by fine structure features at 275–280 nm (Fig. 2A).
Q987K variant displays a near-UV CD spectrum almost identical
to that of the wild-type as well as D927G and N1128I, which
nevertheless show a slight decrease of the dichroic activity at 275–
280 nm. In line with the near-UV CD results, which suggest a
similar tertiary arrangement for the wild-type and all the variants,
the fluorescence emission spectra of mutants are similar to that of
wild-type protein, being all centred at the same maximum
emission wavelength around 338 nm but characterized by a
decreased emission fluorescence intensity (Fig. 2B). Far-UV CD
spectra of all the PTPr mutants superimpose well with that of the
wild-type and are typical of an alpha and beta protein, showing a
local minimum at around 208 nm, a 200 nm zero intercept and a
1.13 ratio of the 208/222 bands (Fig. 2C). These results indicate
that the SNP mutations had no effect on the secondary structure of
the protein and suggest that, in the native state, the effect of the
mutations are directed and localized to the mutated residue with
minor modification of tertiary arrangements.
Thermal unfolding
The thermal stability of D927G, Q987K and N1128I was
investigated by continuously monitoring the ellipticity changes at
209 nm between 10 and 72uC in comparison with that of wild-type
(Fig. 3). The parameter chosen to compare the transition curves of
PTPr wild-type and mutants is the melting temperature (Tm)
defined as the mid point of the denaturation process calculated by
plotting the first derivative of the molar ellipticity values as a
function of temperature (Fig. 3, inset). The temperature-induced
ellipticity changes at 209 nm, where the main amplitude was
observed, occur in an apparent cooperative transition for PTPr
wild-type, Q987K, N1128I and D927G, and with apparent Tm
values of 43.0, 42.0, 41.0 and 40.0uC, respectively. The tempera-
ture-induced ellipticity changes for wild type and mutants are all
coincident with the heat-induced increase of the photomultiplier
tube voltage (PMTV) above 370 V (Fig. 3B), suggesting that the
temperature-induced unfolding is accompanied by protein aggre-
gation [25]. Aggregation occurred also when thermal scans were
performed at a lower heating rate with a low-temperature shifts of
the apparent Tm; the differences between the apparent Tm of wild
typeandvariantswere the same asthosemeasuredathigherheating
rate (data not shown). The observed transitions are irreversible as
indicated by the spectra measured at the end of the cooling phase
that differ from those of the native proteins measured at the
beginning of the thermal transitions (data not shown). Furthermore,
inspection of the cuvette at the end of the cooling phase revealed the
presence of a large amount of precipitate in all the samples.
Figure 2. Spectroscopic properties of PTPr wild-type and
mutants. (A) Near-UV CD spectra were recorded in a 1-cm quartz
cuvette at 1.0 mg/ml protein concentration in 20 mM Tris/HCl, pH 7.5
containing 0.2 M NaCl and 2 mM DTT. (B) Intrinsic fluorescence
emission spectra were recorded at 0.04 mg/ml protein concentration
(295 nm excitation wavelength) in 20 mM Tris/HCl, pH 7.5 containing
0.2 M NaCl and 200 mM DTT. (C) Far-UV CD spectra were recorded in a
0.1-cm quartz cuvette at 0.2 mg/ml in 20 mM Tris/HCl, pH 7.5
containing 0.2 M NaCl and 0.4 mM DTT.
doi:10.1371/journal.pone.0032555.g002
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The temperature dependence of phosphatase activity of PTPr
wild-type and variants was examined over the temperature range
of 10–42uC (Fig. 4A). The optimal temperatures were estimated to
be at 37uC for wild type and Q987K, at around 33uC for N1128I
and at 30uC for D927G (Fig. 4A). Notably, at 37uC, the
phosphatase activity of all PTPr variants is significantly reduced
and corresponds to 72, 54 and 20% of that of the wild-type protein
for Q987K, N1128I and D927G, respectively. The activation
energy, Ea
{, determined by the Arrhenius equation (1) in the
temperature range between 10uC and the optimal temperature of
each protein, corresponds to 13.8860.40 kcal/mol for the wild-
type and to 12.7760.51, 10.7360.54 and 11.3860.46 kcal/mol
for N1128I, D927G and Q987K (Fig. 4B), respectively. This result
suggests an increased flexibility of all the variants compared to the
wild-type, particularly evident for N1128I and D927G whose
phosphatase activity is significantly decreased at 42uC. The
comparison of temperature dependence of phosphatase activity
with the structural thermal unfolding monitored at 209 nm clearly
indicates that the D927G and N1128I variants are significantly
more flexible and less thermal resistant than the wild-type.
Urea-induced equilibrium unfolding transitions
PTPr wild-type and variants reversibly unfold in urea at 10uC
in 20 mM TrisHCl, pH 7.5, containing 200 mM DTT and 0.2 M
NaCl. The effect of increasing urea concentrations (0–8 M) on the
structure of PTPr mutants was analyzed by far-UV CD and
intrinsic fluorescence emission spectroscopy and compared to the
wild-type.
Incubation of PTPr wild-type and variants at increasing urea
concentrations at 10uC for 30 min, a time sufficient to reach the
equilibrium, resulted in a progressive change of the intrinsic
fluorescence emission intensity and a red-shift of the maximal
emission wavelength. At the end of the transition, above 7 M urea,
the intrinsic fluorescence emission intensity is increased about 1.5
fold and the maximal fluorescence emission wavelength shifts to
around 358 nm either for the wild-type and all the variants (Fig. 5).
Determination of the red-shift of the intrinsic fluorescence
emission was obtained by calculating the intensity averaged
emission wavelength l at increasing urea concentration (Fig. 6A).
This parameter is an integral measurement, negligibly influenced
by the noise, and reflects changes in both the shape and the
position of the emission spectrum.
The same samples used to monitor the fluorescence emission
changes during the unfolding transition were used to monitor far-
UV CD ellipticity (Fig. 6A). The unfolding process is fully
reversible upon dilution of the denaturant, either for the wild-type
as well as for all the mutants (Fig. 6A). The urea-induced changes
in intensity averaged emission wavelength l and in 222 nm
ellipticity of all the mutants are similar to that of the wild-type and
show a sigmoidal dependence on urea concentration, following an
apparent two-state transition. However, the transitions monitored
by ellipticity changes and l changes do not coincide (Fig. 6A)
suggesting the possible presence of an intermediate in the
transition region at approximately 4 M urea for the wild-type
and for all the variants. The plot of the relative fluorescence
intensity changes versus urea concentration shows a complex
dependence upon increasing denaturant concentration for the
wild-type and all the mutants (Fig. 6B). The data in Fig. 6B clearly
indicate a non two-state unfolding process and the population of a
denaturation intermediate at about the same urea concentration of
the apparent denaturation midpoints observed by ellipticity and l
averaged changes (Fig. 6 A and B). The folding intermediate
detected by relative fluorescence intensity is populated at around
4.45 M urea for wild-type and Q987K and at around 3.95 M urea
for D927G and N1128I. The intrinsic fluorescence emission
spectra of the folding intermediate are similar for all the proteins:
the fluorescence intensity is increased of about 1.5 fold and the
maximum emission wavelength is shifted from 338 to 345 nm,
with respect to the native state (Fig. 5). The hyperfluorescent
intermediate of wild-type and variants retains about 35% of the
222 nm ellipticity of the native state (Fig. 6A).
The transitions monitored by relative fluorescence intensity
changes (Fig. 6B) were fitted to a three-state unfolding process
which yielded the thermodynamic parameters for wild-type and
the variants of PTPr (Table 1). For the first transition, m values are
all closely similar to that of the wild-type, suggesting a similar
unfolding mechanism for all the variants; DG values lower than
that of the wild-type are observed for N1128I and D927G,
Figure 3. Thermal transition of PTPr wild-type and mutants. (A)
PTPr wild-type, N1128I, Q987K and D927G were heated from 10uCt o
72uC in a 0.1-cm quartz cuvette at 0.2 mg/ml in 20 mM Tris/HCl, pH 7.5
containing 0.2 M NaCl and 0.4 mM DTT. The dichroic activity at 209 nm
was monitored continuously every 0.5uC. The inset shows the first
derivative of the same data. (B) PMTV data recorded in the same
experiments shown in (A).
doi:10.1371/journal.pone.0032555.g003
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variants, that also show a decreased thermal stability (see Fig. 3
and 4). For the second transition, that represents the unfolding of
the intermediate to the denatured state, the m values of all the
proteins are lower than those of the first transition, indicating that
a larger increase in solvent-exposed surface area occur in the
unfolding from the native to the intermediate state (Table 1).
Notably, DG values relative to the second unfolding transition for
N1128I and Q987K are larger than those relative to the first
transition, suggesting a higher stability of the intermediate states,
compared to that of the wild-type.
The near-UV CD changes of D927G, the most temperature
sensitive variant, upon increasing urea concentrations were
monitored in comparison with wild-type (Fig. 7) to better
characterize the nature of the intermediate state. The resulting
data were analyzed after removal of the high-frequency noise and
the low-frequency random error by a singular value decomposition
algorithm (SVD) which resolved two main spectra components
either for wild-type or for the mutant D927G. The most significant
singular values were 2.05610
3 for wild-type and 1.96610
3 for
D927G, the second singular values were 38.2% and 40.1% of the
first singular value for wild-type and D927G, respectively. The
plots of the first (V1) and of the second column (V2) of the V matrix
which reflect the global change in the 250–320 nm region as a
function of urea concentration show non-two state transition
profiles comparable to the transitions monitored by intrinsic
fluorescence emission intensity and confirm the accumulation of
an intermediate at around 4.2 M urea (Fig. 7 B, and C). At this
denaturant concentration, the near-UV CD spectra of wild-type
and D927G significantly differ from those of the native state and
are completely opposite in sign (Fig. 7A). The 298 nm negative
band is lost and a positive contribution at 289 nm is present in the
spectra of the intermediate state of both proteins. Furthermore, the
280–260 nm region, dominated by contribution of Phe and Tyr
residues, in D927G is less defined than the wild-type (Fig. 7A). The
data clearly indicate that both the spectral components of the wild-
type and D927G contribute to the urea induced transitions with
the accumulation of a denaturation intermediate at the same urea
concentration range observed by monitoring intrinsic fluorescence
intensity (Fig. 5 and Fig. 6B).
Theurea-induced unfoldingtransitionsmonitoredbyfar-UVCD
ellipticity changes are non-coincident with those monitored by
fluorescence (Fig. 6) and near-UV CD (Fig. 7). To identify the
number of spectral components contributing to the urea-induced
ellipticity changes, far-UV CD spectra were analysed after removal
of the high-frequency noise and the low-frequency random error by
SVD. The global changes in the spectral region 213–250 nm,
analyzed by SVD, indicate that only two spectral components
contribute to the far-UV CD spectra of wild-type and all the
variants. The most significant singular values are very similar for
wild-type and all the variants and range between 1.76610
5 and
1.67610
5. The second singular values are 19.8% of the first singular
value for the wild-type, 16.6% for the D927G variant, 11.2% for
Q987K and 8.0% for N1128I. All the other singular values are
below 7.0% of the largest singular value and progressively decrease
approaching to zero. The plots of the first column of the V matrix
(V1), which reflect the global change in the 213–250 nm region, as a
function of urea concentration (data not shown) show sigmoidal
transition profiles comparable to the transitions monitored at
222 nm for the wild-type and the variants (data not shown). Non
cooperative changes of V2 at increasing denaturant are observed.
Furthermore, the reconstituted spectra of the first spectral
component superimposed well with those of the sum of the first
andthe secondspectralcomponent (data not shown),indicatingthat
Figure 4. Effect of temperature on phosphatase activity of PTPr wild-type and mutants. (A) Temperature dependence of phosphatase
activity of PTPr wild-type and mutants. (B) Non-linear fit of the temperature dependence of phosphatase activity to the Arrhenius equation (Eqn. 1);
the inset shows the linear Arrhenius plot for the same data. Assays were performed under the conditions described in Materials and Methods, using
1 nM enzyme.
doi:10.1371/journal.pone.0032555.g004
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transitions monitoredby ellipticityat 222 nm.These results indicate
an apparent two-state process for far-UV CD unfolding transitions
of wild-type and variants. Thus the data have been globally fitted to
a two-state model according to equation 4 with the m parameter
shared between all the data sets. The free energy of unfolding,
DG
H
2
O, of wild-type and mutants obtained from the global fit-
ting are very similar and correspond to 3.5660.09, 3.6360.10,
3.6560.10 and 3.8260.07 kcal/molfor wild-type, N1128I, D927G
and Q987 K, respectively, for a shared m value of 1.0660.05 kcal/
mol/M. Equilibrium unfolding of PTPr wild-type and variants
occurs via a hyperfluorescent intermediate state that cannot be
detected by far-UV CD. Hence, the thermodynamic folding
intermediate may represent a conformational change which occurs
in the proximity of any of the tryptophans most likely due to an
increase of native state flexibility [26].
Figure 5. Intrinsic fluorescence emission spectra of PTPr wild-type and mutants. Fluorescence spectra of PTPr wild-type and mutants in
0 M (continuous lines), 8.30 M (dotted lines), 3.95 M (D927G and N1128I, dashed lines) and 4.45 M urea (wild-type and Q987K, dashed lines) were
recorded at 0.04 mg/ml protein concentration (295 nm excitation wavelength) at 10uC in 20 mM Tris/HCl, pH 7.5 containing 0.2 M NaCl and 200 mM
DTT.
doi:10.1371/journal.pone.0032555.g005
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PTPr, which belongs to the classical receptor type IIB family of
PTP, is one of the most frequently mutated PTP in human cancers
[1,24]. In this study we investigated the effect of amino acid
substitution on the thermal and thermodynamic stability and on the
activity, of the membrane-proximal catalytic D1 domain of PTPr.
Catalytically active fragments of several PTPs of type IIB family are
proteolytically cleaved and released within the cytoplasm of tumour
cells [27–29], hence the biophysical characterization of this catalytic
domain may be relevant. The D1 domain is a monomeric,
structurally independent and stable folding unit characterized by
a high thermodynamic stability. In this study, we selected PTPr
mutations of D1 domain found in colorectal cancers [10] and
reported in nsSNP database [14], D927G, Q987K, A1118P and
N1128I. All the mutants are expressed as soluble recombinant
proteins, except A1118P which remains insoluble also upon
different growth and induction conditions. The spectroscopic
properties of the wild-type compared with those of all the variants
indicate that the mutations D927G, Q987K and N1128I had no
effect on protein secondary structure with minor modifications of
tertiary arrangements.
All the mutants show a decrease in the thermal stability and in
the activation energy for phosphatase activity with respect to the
wild-type indicating an increase in protein flexibility of all the
mutants. Hence, at 37uC the phosphatase activity of all the
variants was significantly reduced, similarly to what reported by
Wang et al. for Q987K and N1128I [10]. The most destabilizing
mutation, D927G, yielded a protein that at physiological
temperature was almost completely inactive.
All the mutations studied here are located at very diverse
positions in the structure, distant from the catalytic site and, except
A1118P, in solvent-exposed loop regions. Presumably, the change
in main chain flexibility caused by the most destabilizing D927G
mutation may lead to local disorder and may affect the stabilizing
hydrogen bonds of residues in close proximity (Asp-947, Lys-930
and Glu-931). This hypothesis is in agreement with the changes in
local environment of aromatic residues suggested by the
comparison of the near-UV CD spectrum of D927G with that
of the wild-type. The N1128I mutation is less destabilizing than
D927G. In the wild-type structure N1128, about 50% solvent
accessible, is located in a very polar environment at the C-
terminus of helix 8 and is involved, through its peptidic nitrogen,
in a hydrogen bond with the peptide carbonyl of Asp-1124. The
susbtitution of a polar residue, Asn-1128, to a nonpolar residue,
Ile, may also contribute to destabilize the N1128I mutant. Q987K
is the least destabilizing mutation with regard to thermal stability
and temperature dependence of phosphatase activity, probably
due to the fact that Gln-987 in the wild-type structure is not
involved in any interaction with other protein residues.
All the variants, as revealed by intrinsic fluorescence emission
intensity, show three-state equilibrium unfolding transitions similar
to that of the wild-type, with the accumulation of a hyperfluorescent
intermediate at ,4.0 M urea that retains 35% of the native
secondary structure ellipticity. The hyperfluorescent intermediate of
wild-type and of D927G, the most temperature sensitive variant,
contains tertiary contacts, although the packing of aromatic side-
chains appears different from that of the native state.
Figure 6. Urea-induced equilibrium unfolding of PTPr wild-
type and mutants. (A) Normalized intensity-averaged emission
wavelength (l, left axis, filled circles) and molar ellipticity at 222 nm
reported after removal of the high-frequency noise and the low-
frequency random error by SVD ([H]222, right axis, empty squares); the
continuous lines represent the nonlinear global fitting of the molar
ellipticities at 222 nm data to Eqn. 4 for PTPr calculated as described in
Materials and Methods. (B) Normalized relative fluorescence intensities
at 338 nm; the continuous lines represent the nonlinear regression fit of
the relative fluorescence intensities at 338 nm to Eqn. 6 calculated as
described in Materials and Methods. The reversibility points (empty
circles) are shown, for clarity, only for the relative fluorescence
intensities of the wild-type and were not included in the nonlinear
regression analysis. All spectra were recorded at 10uC as described in
Materials and Methods.
doi:10.1371/journal.pone.0032555.g006
Table 1. Thermodynamic parameters for urea-induced
unfolding equilibrium of PTPrwild-type and mutants.
Wild-type N1128I D927G Q987K
mI-N (kcal/mol/M) 2.9460.32 2.4360.28 2.6960.45 2.9860.27
D50I-N (M) 3.5160.02 3.3460.03 3.4660.03 3.5860.02
DG
H
2
O
I-N (kcal/mol) 10.32 8.12 9.31 10.67
mU-I (kcal/mol/M) 1.6160.13 1.9160.18 1.8160.26 2.5160.25
D50U-I(M) 5.4960.03 5.4060.03 5.3160.05 5.0660.02
DG
H
2
O
U-I (kcal/mol) 8.84 10.31 9.61 12.70
Urea-induced unfolding equilibrium data were obtained at 10uC in 20 mM Tris/
HCl, pH 7.5, containing 0.2 M NaCl and 200 mM DTT by measuring the relative
fluorescence intensity at 338 nm. The free energy of unfolding from the native
state to the intermediate (DG
H
2
O
I-N) and from the intermediate to the unfolded
state (DG
H
2
O
U-I) were calculated from Eqn. 5. D50I-N and mI-N which are the
midpoint and m value for the transition between native and intermediate state,
respectively, and D50U-I and mU-I are the midpoint and m value for the
transition between the intermediate and the unfolded state, respectively, were
calculated from Eqn.6. Data are reported 6 SE of the fit.
doi:10.1371/journal.pone.0032555.t001
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low temperature allows a quantitative determination of the effect
of mutations on the thermodynamic parameters of PTPr catalytic
domain. The destabilizing effect of mutations caused by nsSNPs
on PTPr thermodynamic stability (Table 1) may be referred i) to a
destabilization of the native state for N1128I and D927G, as
indicated by the values of DG
H
2
O
I-N lower than that of the wild-
type, and ii) to a stabilization of the intermediate for all the
variants, as suggested by the higher free energy of unfolding from
the intermediate to the unfolded state (DG
H
2
O
U-I), with respect to
that of the wild-type (Table 1). The destabilizing effect of D927G
and N1128I substitutions is also evident from the decrease in
melting temperature monitored by secondary structure changes
and from the significant reduction of phosphatase activity at 37uC
that suggests a higher flexibility of the two variants with respect to
the wild-type.
The reversible equilibrium unfolding transitions monitored by
far-UV CD are not coincident with those monitored by near-UV
CD and intrinsic fluorescence emission intensity and do not reveal
any denaturation intermediate. The thermodynamic parameters
relative to the apparent two-state equilibrium unfolding measured
by far-UV CD do not indicate any significant difference between
the variants and the wild-type and are lower than those
determined by intrinsic fluorescence emission intensity. In
particular, the shared m value of 1.06 kcal/mol/M calculated
from global fitting of the far-UV CD equilibrium unfolding data is
significantly lower than the predicted m value for a monomeric
protein of 280 amino acid residues unfolded in urea which is
3.7160.3 kcal/mol/M [30], a value closely similar to that measured
by fluorescence intensity. As a matter of fact, fluorescence intensity is
extremely sensitive to the microenvironment of a fluorophore and is
considered as the most straightforward signal that can be related to
thermodynamics of unfolding transitions [31]. The discrepancy
between the thermodynamic parameters obtained by far-UV CD
and fluorescence intensity and the lack of a detectable intermediate
by far-UV CD may indicate that the hyperfluorescent intermediate
state represents conformational changes which occur in the
proximity of any of the tryptophans, with an alternative tertiary
arrangement. In the native state, the maximum emission wavelength
(lmax=338 nm) indicate that tryptophan residues are shielded
from the solvent, whereas a partial exposure of tryptophan residues
to the solvent is observed for the intermediate (lmax=345 nm).
These results are in agreement with the structural data which
indicate that in PTPr two out of the five tryptophans, Trp-994 and
Trp-998, are located in the same helical region (helix 6) and Trp-
926, Trp-1023 and Trp-1072 are placed in coil regions. All the five
tryptophans are almost completely buried. In the native state the
solvent accessibility of the five chromophores is 15% for Trp-998,
14% for Trp-926 and 4% for Trp-1023, whereas all the other
tryptophan residues are completely buried. Hence, at approximately
4.0 M urea, it is impossible to assign to any of the five chromophores
a particular role in the fluorescence properties of the intermediate
state.
In conclusion our results revealed a destabilizing and inactivat-
ing role of the mutations of PTPr D1 domain found in colorectal
cancers [10]. All the amino acid mutations studied here are on the
surface of PTPr and could potentially participate in protein-
protein interactions. The stabilization of a folding intermediate,
Figure 7. Effect of urea on near-UV CD spectra of PTPr wild-type and D927G. (A) Near-UV CD spectra of wild-type and D927G in 0 M,
4.28 M and 7.31 M urea were recorded in a 1-cm quartz cuvette at 2.4 mg/ml protein concentration at 10uC in 20 mM Tris/HCl, pH 7.5 containing
0.2 M NaCl and 2 mM DTT. (B) and (C) Near-UV CD changes of wild-type and D927G at increasing urea concentrations reported as the first (V1, B) and
the second (V2, C) column of the V matrix. V1 and V2 were obtained by SVD of the near-UV CD spectral data as described in the text.
doi:10.1371/journal.pone.0032555.g007
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role in recognition and interaction with other substrate proteins as
well as in sensitivity of this phosphatase to degradation.
Materials and Methods
Site-directed mutagenesis
PTPr wild-type enzyme plasmid was obtained by SGC (Oxford)
[8]. Quick Change Site-Directed Mutagenesis Kit (Stratagene) was
used to introduce the single mutations on wild-type PTPr plasmid
used as template. The mutagenic oligonucleotides used are listed
in Table 2.
Protein Expression and Purification
PTPr wild-type and mutants were expressed in E. coli strain
BL21(DE3). 10 ml of overnight culture was grown at 37uCi n1L
LB media containing kanamycin as antibiotic at a final
concentration of 50 mg/ml until optical density OD600 reached
0.6. The culture was cooled on ice for 20 min, then the protein
expression was induced overnight by adding 0.5 mM isopropyl-b-
D-thiogalactoside (Sigma-Aldrich) and grown overnight at 15uC
with energic shaking. The culture was harvested by centrifugation
and resuspended in 50 ml of Binding buffer (50 mM Hepes,
500 mM NaCl, 5 mM Imidazole, 5% Glycerol, pH 7.5) contain-
ing 0.5 mM tris(2-carboxyethyl)phosphine, and stored at 220uC
until use. The cells were thawed on ice supplemented with
protease inhibitors (Complete, Roche) and disrupted by sonica-
tion. The lysate was cleared by centrifugation and the supernatant
was loaded on a DE52 column (GE Healthcare), previously
equilibrated with Binding buffer and 0.5 mM tris(2-carboxyethyl)-
phosphine, to remove nucleic acids. The flow-through was loaded
on a Ni-NTA (Ni
2+- nitriltriacetate) affinity column (GE
Healthcare) pre-equilibrated with Binding buffer. The column
was washed with Binding buffer to elute weakly bound
contaminants. The recombinant protein was eluted by passing
over the column binding buffer solutions containing increasing
imidazole concentrations (50 mM, 100 mM, 150 mM and
250 mM, respectively). The collected eluates were supplemented
with a final concentration of 10 mM dithiothreitol (DTT) and
tested for purity on SDS gel using precasted gel system
(Invitrogen). The pure fractions were incubated overnight with
tobacco etch virus protease (Pro-TEV), to remove the hexahisti-
dine tag. After digestion, the protein was concentrated to 2 ml
using Millipore concentrators and loaded onto a Superdex 200
300/10 gel filtration column previously equilibrated with 50 mM
Tris/HCl, 0.25 M NaCl, 10 mM DTT, pH 7.5 at a flow rate of
1.0 ml/min. 2 ml fractions were collected and the pure protein
was identified by SDS PAGE. Protein concentration was
determined spectrophotometrically using a molar absorptivity of
49850 M
21 cm
21 at 280 nm based on a molecular mass of
35.190 kDa.
Temperature dependence of phosphatase activity
The activity assay mixture containing 20 mM Tris-HCl pH 7.5,
200 mM NaCl, 5 mM CaCl2, 250 mM DTT, and 100 mM of 6,8-
difluoro-4- methylumbelliferyl phosphate (Molecular Probes
D6567) in a 0.5 ml final volume was incubated at increasing
temperature in a thermostated cuvette. Reaction was started by
adding 2–4 ml of purified enzyme at 10uC to 0.5 ml assay mixture
equilibrated at the desired temperature. The final enzyme
concentration was 1 nM. The solution was thoroughly mixed by
pipetting and the fluorescence at 460 nm (360 nm excitation
wavelength) was continuously monitored for 360 s in the
thermostated cuvette. The fluorescence changes between 150
and 300 s were extrapolated to a standard curve of 6,8-difluoro-7-
hydroxy-4-methylcoumarin (Molecular Probes) monitored under
the same conditions. The 6,8-difluoro-4- methylumbelliferyl
phosphate concentration was well below the Km of the wild-type
(753 mM) [10] and substrate consumption did not exceed 0.4%,
hence the first order rate constant for phosphatase activity, k=s
21,
is obtained from [6,8-difluoro-7- hydroxy-4-methylcoumar-
in]6s
21/[enzyme]. The temperature dependence was fitted
nonlinearly to the Arrhenius equation using GraphPad Prism
4.0 to obtain the activation energies (Ea
{) for the catalytic reaction
k~Ae{Ea=RT ð1Þ
where k (s
21) is the rate constant at temperature T (K), A is a
reaction specific quantity, R the gas constant (1.987 cal6
mol
216K
21) and Ea the activation energy of the reaction. Hence,
a plot of ln k versus 1/T gives a straight line with the slope being
2Ea/R.
Spectroscopic measurements
Intrinsic fluorescence emission measurements were carried out
at 10uC with a LS50B spectrofluorimeter (Perkin-Elmer), at
40.0 mg/ml protein concentration, using a 1.0 cm path length
quartz cuvette. Fluorescence emission spectra were recorded from
300–450 nm (1 nm sampling interval), with the excitation
wavelength set at 295 nm. Far-UV (190–250 nm) CD spectra
were recorded either at a protein concentration of 0.20 mg/ml in
a 0.1 cm cuvette or at 40.0 mg/ml in a 0.5 cm cuvette; near-UV
(250–320 nm) CD spectra were recorded at protein concentration
ranging from 1.0 to 2.4 mg/ml in a 1.0 cm cuvette. Far- and near-
UV CD spectra were measured using 0.1, 0.5 and 1.0 cm path
length quartz cuvettes and the results obtained were expressed as
the mean residue ellipticity [H], assuming a mean residue
molecular mass of 110 per amino acid residue. All spectroscopic
measurements were carried out at 10uC in 20 mM Tris/HCl,
pH 7.5 containing 0.2 M NaCl and 200 mM or 2 mM DTT.
Urea-induced equilibrium unfolding
For equilibrium transition studies, PTPr wild-type and variants
(final concentration 40.0 mg/ml) were incubated at 10uCa t
increasing concentrations of urea (0–8 M) in 20 mM Tris/HCl,
pH 7.5, in the presence of 0.2 M NaCl and 200 mM DTT. After
10 min, equilibrium was reached and intrinsic fluorescence
emission and far-UV CD spectra (0.5-cm cuvette) were recorded
in parallel at 10uC. To test the reversibility of the unfolding, PTPr
Table 2. Primers sequences for mutagenesis of PTPr.
Mutant Primer sequences (59 to 39)
Q987K Forward: GCGACTCAAGGTCCGATGAAGGAGACTGTAAAGGAC
Reverse: GTCCTTTACAGTCTCCTTCATCGGACCTTGAGTCGC
A1118P Forward:CGGACTGGCTGCTTCATTCCCATTGACACCATGCTTGACATGGC
Reverse:GCCATGTCAAGCATGGTGTCAATGGGAATGAAGCAGCCAGTCCG
N1128I Forward: GCTTGACATGGCCGAGATTGAAGGGGTGGTGG
Reverse: CCACCACCCCTTCAATCTCGGCCATGTCAAGC
D927G Forward: GCAGACAGCTTCGTGGGGCACAGCCAAGGAGG
Reverse: CCTCCTTGGCTGTGCCCCACGAAGCTGTCTGC
Mutations were introduced using a Quick Change Site-Directed Mutagenesis Kit
(Stratagene) with the listed primers.
doi:10.1371/journal.pone.0032555.t002
PTP r Mutants Stability
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e32555wild-type and variants were unfolded at 10uC in 7.0 M urea at
0.4 mg/ml protein concentration in 25 mM Tris/HCl, pH 7.5, in
the presence of 2 mM DTT and 0.2 M NaCl. After 10 min,
refolding was started by 10-fold dilution of the unfolding mixture
at 10uC into solutions of the same buffer used for unfolding
containing decreasing urea concentrations. The final enzyme
concentration was 40 mg/ml. After 24 h, intrinsic fluorescence
emission and far-UV CD spectra were recorded at 10uC.
Thermal denaturation experiments
PTPr variants and wild-type (0.20 mg/ml) were heated from
10uCt o7 2 uC in a 0.1 cm quartz cuvette with a heating rate of 1.0
and 0.5 degree6min
21 controlled by a Jasco programmable
Peltier element. The dichroic activity at 209 nm and the PMTV
were continuously monitored in parallel every 0.5uC [25]. All the
thermal scans were corrected for the solvent contribution at the
different temperatures. Melting temperature (Tm) values were
calculated by taking the first derivative of the ellipticity at 209 nm
with respect to temperature. All denaturation experiments were
performed in triplicate.
Data analysis
The changes in intrinsic fluorescence emission spectra at
increasing urea concentrations were quantified as the decrease of
relative fluorescence intensity at 345 nm or as the intensity-
averaged emission wavelength, l, [32] calculated according to
l~
X
Iili ðÞ
.X
Ii ðÞ ð 2Þ
where li and Ii are the emission wavelength and its corresponding
fluorescence intensity at that wavelength, respectively. This
quantity is an integral measurement, negligibly influenced by the
noise, which reflects changes in the shape and position of the
emission spectrum. Urea-induced equilibrium unfolding transi-
tions monitored by far-UV CD ellipticities changes was analysed
by fitting baseline and transition region data to a two-state linear
extrapolation model [33] according to
DGunfolding~DGH2Ozm urea ½  {RT ln Kunfolding ð3Þ
Where DGunfolding is the free energy change for unfolding for a
given denaturant concentration, DG
H
2
O the free energy change for
unfolding in the absence of denaturant and m a slope term which
quantifies the change in DGunfolding per unit concentration of
denaturant, R the gas constant, T the temperature and Kunfolding
the equilibrium constant for unfolding. The model expresses the
signal as a function of denaturant concentration:
yi~
yNzsN½X iz yUzsU½X i
  
  exp {DGH2O{m½X i
  
=RT
  
1zexp
{DGH2O{m½X i
  
RT
   ð4Þ
where yi is the observed signal, yU and yN are the baseline
intercepts for unfolded and native protein, sU and sN are the
baseline slopes for the unfolded and native protein, [X]i the
denaturant concentration after the ith addition, DG
H
2
O the
extrapolated free energy of unfolding in the absence of denaturant,
m the slope of a DGunfolding versus [X] plot. Data were globally
fitted with the m values shared between the data sets; all other
parameters were not constrained. The denaturant concentration
at the midpoint of the transition, [urea]0.5, according to equation
3, is calculated as:
urea ½  0:5~DGH2O 
m ð5Þ
The denaturation curves obtained by plotting the relative
fluorescence intensities changes induced by increasing urea
concentrations were fitted to the following equation assuming a
three-state model:
F~
FNzexp mI-N
½urea {D50I-N
RT
  
. FIzFUexp mU-I
½urea {D50U-I
RT
     
1zexp mI-N
½urea {D50I-N
RT
  
. 1zexp mU-I
½urea {D50U-I
RT
      ð6Þ
where F is the observed fluorescence intensity, m is a constant that
is proportional to the increase in solvent-accessible surface area
between the two states involved in the transition, D50I-N and mI-N
are the midpoint and m value for the transition between N and I,
respectively, and D50U-I and mU-I are the midpoint and m value for
the transition between I and U, respectively [34]. The fluorescence
intensity of the intermediate state (I), FI, is constant whereas that of
the folded state (N) and of the unfolded state (U), FN and FU,
respectively, has a linear dependence on denaturant concentration
FN~aNzbN urea ½  ð 7Þ
FU~aUzbU urea ½  ð 8Þ
where aN and aU are the baseline intercepts for N and U, bN and
bU are the baseline slopes for N and U, respectively. All unfolding
transition data were fitted by using Graphpad Prism 4.0.
Far-UV CD spectra recorded as a function of urea concentra-
tion were analyzed by SVD using the software MATLAB (Math-
Works, South Natick, MA) to remove the high frequency noise
and the low frequency random errors and to determine the
number of independent components in any given set of spectra.
CD spectra in the 213–250 nm or in the 250–320 nm region were
placed in a rectangular matrix A of n colu mns, one column for
each spectrum collected at each time. The A matrix is decomposed
by SVD into the product of three matrices: A=U*S*V
T, where U
and V are orthogonal matrices and S is a diagonal matrix. The U
matrix columns contain the basis spectra and the V matrix
columns contain the urea dependence of each basis spectrum.
Both U and V columns are arranged in terms of decreasing order
of the relative weight of information, as indicated by the
magnitude of the singular values in S. The diagonal S matrix
contains the singular values that quantify the relative importance
of each vector in U and V. The signal-to-noise ratio is very high in
the earliest columns of U and V while the random noise is mainly
accumulated in the latest U and V columns. The wavelength
averaged spectral changes induced by increasing denaturant
concentrations are represented by the columns of matrix V;
hence, the plot of the columns of V versus the denaturant
concentrations provides information about the observed transition.
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